Men can raise testosterone and preserve fertility with HPG-sparing options like enclomiphene, clomiphene, and hCG co-therapy. Here is what the evidence shows.
Men can raise testosterone and preserve fertility with HPG-sparing options like enclomiphene, clomiphene, and hCG co-therapy. Here is what the evidence shows.
Yes, but the path matters enormously. Standard testosterone replacement therapy raises your testosterone numbers, and it does it well, but it does so by flooding the body with testosterone from outside, which signals the brain to stop asking the testes to produce anything at all. The result is predictable: sperm production drops, often to zero [1].
Here is the biology in plain terms. Your body runs on a feedback loop called the hypothalamic-pituitary-gonadal (HPG) axis, think of it as a thermostat chain. The hypothalamus (the brain's hormone command center) releases a signal, which tells the pituitary gland to release two hormones: luteinizing hormone (LH) and follicle-stimulating hormone (FSH). LH tells the testes to make testosterone; FSH tells them to make sperm (a process called spermatogenesis). Exogenous testosterone, meaning testosterone that comes from a prescription vial rather than your own body, convinces the brain the thermostat is satisfied. The pituitary goes quiet, LH and FSH fall, and the testes receive no signal to do either job [2].
The practical consequence is serious. Azoospermia, a sperm count of zero, occurs in a meaningful proportion of men on conventional TRT [1]. For a man in his 30s or 40s who wants children now or later, that is not a theoretical footnote.
The good news is that HPG-sparing alternatives exist. Options like enclomiphene citrate, clomiphene citrate, and hCG co-therapy each work through different points in that same thermostat chain to raise testosterone while keeping the fertility signal alive [2]. Understanding how each one works, and who it fits best, starts with the mechanism.
For a broader overview of conventional therapy, see what TRT actually involves and how fertility is affected.
Add testosterone from outside the body and your brain reads it as "enough, stop making your own." That shutdown happens at the level of the hypothalamic-pituitary-gonadal (HPG) axis, the three-station signaling chain that runs from brain to testes, and it moves faster than most men expect.
Here is the chain in plain terms. The hypothalamus (the brain's master regulator) fires pulses of GnRH, a chemical messenger, roughly every 90 minutes. Those pulses tell the pituitary gland to release LH, a hormone that travels to the Leydig cells inside the testes and instructs them to make testosterone locally. That local testosterone, called intratesticular testosterone, is what actually drives sperm production. The concentration required inside the testes to sustain spermatogenesis is far higher than what circulates in the bloodstream. When you inject exogenous testosterone, blood levels rise, the hypothalamus detects the surplus, and it cuts GnRH output. LH drops. The Leydig cells go quiet. Intratesticular testosterone collapses, and sperm production follows [3].
The timeline matters. Research has documented azoospermia (zero measurable sperm) or severe oligospermia (sperm counts below one million per milliliter) in men using exogenous testosterone [1]. Recovery after stopping is not instant: the HPG axis can take months to resume adequate signaling, and in some cases the recovery is incomplete [1]. A review in Asian Journal of Andrology noted that testosterone-only contraceptive regimens reliably suppress sperm in East Asian men and less consistently in Caucasian men, which suggests individual recovery trajectories vary as well [4].
The practical takeaway: fertility loss on standard TRT is not a rare side effect. It is the expected physiological outcome of the mechanism.
| What happens on standard TRT | Why it matters for fertility |
|---|---|
| LH suppressed by exogenous testosterone feedback | Leydig cells stop producing intratesticular testosterone |
| Intratesticular testosterone collapses | Spermatogenesis loses its primary driver |
When the goal is higher testosterone without shutting down sperm production, selective estrogen receptor modulators (SERMs) are the most studied option. These drugs block estrogen's feedback signal at the brain, which prompts the pituitary to release more LH (luteinizing hormone, the signal that tells the testes to make testosterone) and FSH (follicle-stimulating hormone, the signal that drives sperm production). The result is more testosterone made by your own testes, with the HPG axis still running.
Clomiphene citrate is actually two molecules packaged together: enclomiphene (the trans-isomer) and zuclomiphene (the cis-isomer). Enclomiphene does the useful work, blocking estrogen receptors at the hypothalamus and pituitary to raise LH and FSH. Zuclomiphene has weak estrogenic activity of its own and clears the body slowly, which is where clomiphene's side-effect profile, including mood changes and visual disturbances, largely originates [5].
Enclomiphene citrate, available as a purified compound, delivers the HPG-stimulating effect without the zuclomiphene burden. A phase III randomized trial comparing enclomiphene citrate to topical testosterone gel in men with secondary hypogonadism found that enclomiphene raised total testosterone while FSH and LH increased, and sperm concentrations stayed within the normal range throughout the 16-week study period. The testosterone gel group saw testosterone rise as well, but "there was a marked reduction in spermatogenesis in the testosterone gel group" [6]. Put plainly: both raised testosterone, but only enclomiphene kept sperm counts intact.
A retrospective study comparing the two agents head-to-head found that both raised total testosterone significantly, but enclomiphene produced a statistically significant increase in LH, FSH, and total motile sperm count, while clomiphene did not reach significance on those measures [7].
| Profile | Enclomiphene or clomiphene fits | TRT fits better |
|---|---|---|
| Wants to conceive now or soon | Yes | No |
| Secondary hypogonadism (pituitary signal is the problem) | Yes | Possibly, with hCG |
| Primary hypogonadism (testes cannot respond) | No | Yes |
| Wants to avoid injections | Yes | Depends on formulation |
| Has very low testosterone with severe symptoms | May be insufficient alone | Yes |
Most men starting enclomiphene notice changes in energy and libido within four to six weeks as testosterone climbs. Lab work at eight weeks typically shows meaningful increases in total testosterone alongside rising LH and FSH [5]. Knowing how to read
When a man starts conventional TRT, his brain reads the extra testosterone in the bloodstream and stops sending the signal that tells his testes to work. Human chorionic gonadotropin, or hCG, is a hormone that mimics that missing signal, keeping the testes stimulated even while exogenous testosterone is on board.
Here is the mechanism in plain terms. Testosterone production inside the testes depends on a local concentration of testosterone that is many times higher than what circulates in the blood. That high internal level is maintained by Leydig cells, the testes' own production units, responding to luteinizing hormone (LH). Exogenous TRT shuts down LH from the pituitary gland, the small gland at the base of the brain that sends the "make testosterone" signal, and Leydig cells go quiet. Without that intratesticular testosterone, sperm production stalls. hCG binds directly to the LH receptor on Leydig cells and keeps them firing, preserving both intratesticular testosterone and spermatogenesis [2].
NOT SURE WHERE TO START?
Take our 2-minute hormone & metabolism quiz to see exactly where you stand. Or skip ahead — a $49 lab panel gives you the numbers, a free hormone screen gives you a plan.
The clinical evidence is consistent. Multiple studies show that low-dose hCG added to TRT sustains sperm production even when gonadotropins are fully suppressed by exogenous testosterone [2]. In a case series of 49 men with testosterone-related azoospermia or severe oligospermia, hCG-based combination therapy led to return of spermatogenesis in 47 of 49 men (95.9%), with a mean time to recovery of 4.6 months [8].
Men who should prioritize hCG co-therapy:
For a detailed look at dosing schedules and injection technique, the hCG in a TRT protocol guide covers the clinical specifics. Men weighing the broader fertility tradeoffs before starting testosterone will find the full picture in TRT and fertility: what every man needs to know.
The next question is when hCG alone is not enough,
The next question is when hCG alone is not enough, and the answer usually comes down to where you are starting and what you are asking the treatment to do. Each option pulls a different lever in the hormonal system, and the tradeoffs are concrete.
| Option | How It Works | Testosterone Achieved | Sperm Impact | Best Fit |
|---|---|---|---|---|
| Enclomiphene citrate | Blocks estrogen receptors in the brain, telling the pituitary to release more LH and FSH | Mean increase to ~805 ng/dL in one case series [9] | Sperm concentration maintained in normal range [6] | Men with secondary hypogonadism who want both T and fertility |
| Clomiphene citrate | Same mechanism; contains both active and less active isomers | Meaningful testosterone increase; less FSH/LH rise than enclomiphene [7] | Sperm motility improved; TMSC increase less consistent [7] | Men who prefer an oral option with decades of clinical familiarity |
| TRT + hCG co-therapy | Exogenous testosterone for levels; hCG mimics LH to sustain intratesticular production | Flexible, protocol-dependent | Spermatogenesis sustained in most men [2] | Men who need reliable testosterone levels and want fertility preserved |
| TRT monotherapy | Exogenous testosterone only; HPG axis suppressed | Flexible, protocol-dependent | Suppresses spermatogenesis; azoospermia risk rises with duration [1] | Men with no near-term fertility goals |
Put plainly: if fertility matters now or in the next few years, TRT monotherapy is the one column in that table you want to avoid.
Delivery method matters almost as much as the molecule itself, and TRT injection and formulation choices shape how consistently any protocol holds your levels day to day.
No prescription changes your hormonal baseline faster than fixing sleep, body composition, and exercise. These are the big dials, and tuning them first reduces how much pharmacological support you may need, sometimes dramatically.
Sleep is the most underrated lever. A review of lifestyle alternatives to testosterone therapy found that sleep deprivation measurably suppresses gonadotropin pulsatility, the rhythmic LH signals that tell your testes to produce testosterone and keep spermatogenesis running [10]. Fix sleep and you restore that signal for free. More detail on the sleep-testosterone connection lives at Sleep, HRV, and Testosterone: The Free Protocol Men Ignore.
Visceral fat, the deep abdominal fat that accumulates with poor diet and inactivity, carries high aromatase activity. Aromatase is the enzyme that converts testosterone into estrogen inside fat tissue. More visceral fat means more conversion, which means lower free testosterone and higher estrogen feedback on the pituitary, which blunts LH output further [10]. That cycle is one reason obesity and low testosterone in young men so often appear together.
The short list of modifiable big dials:
Put plainly: the better your lifestyle foundation, the less work any hormone protocol has to do.
With that foundation in place, lifestyle optimization for men's hormonal health becomes a force multiplier for whatever clinical approach comes next.
Before choosing any protocol, get a baseline snapshot. The lab values you bring to that first conversation determine which options are even on the table, and without a semen analysis before treatment, there is no reliable way to know what the intervention changed.
The minimum pre-treatment panel:
Semen analysis matters more than most men expect. A 2022 study in Andrologia converted men directly from long-acting TRT to Natesto and documented spermatogenesis outcomes, finding that without a baseline, there was no way to confirm what recovered [11]. Similarly, a 2023 retrospective study of obese hypogonadal men treated with clomiphene citrate showed that baseline sperm concentration averaged 4.5 million per mL before treatment, making pre-treatment semen analysis the only reference point for measuring improvement [12].
The questions worth raising with your physician:
Learning how to read your hormone lab report before that appointment puts you in a much stronger position. If you are still mapping your symptoms to a diagnosis, low testosterone symptoms in men is a useful starting point. When you are ready to talk through your specific numbers, reach out to schedule a consultation.
Standard testosterone replacement therapy suppresses sperm production in most men. When you take exogenous testosterone, your brain detects the excess and shuts down LH and FSH signals that tell your testes to produce sperm. Many men on conventional TRT develop azoospermia (zero measurable sperm). However, this is not inevitable. Fertility-sparing alternatives like enclomiphene, clomiphene, and hCG co-therapy can raise testosterone while preserving sperm production by working through different points in your hormonal system.
Three main HPG-axis-sparing approaches exist. Enclomiphene citrate and clomiphene citrate are oral medications that block estrogen feedback at the brain, prompting your pituitary to release more LH and FSH, which stimulate your own testes to produce testosterone and sperm. A second option is adding hCG to testosterone therapy, which mimics the LH signal your brain stops sending, keeping your testes active even while on TRT. All three approaches maintain sperm production while raising testosterone, though which fits best depends on your starting testosterone level and when you want to conceive.
Clomiphene citrate contains two molecules: enclomiphene (the active form) and zuclomiphene (an inactive form that clears slowly). Zuclomiphene causes most of clomiphene's side effects, including mood changes and visual disturbances. Enclomiphene citrate is the purified active compound, delivering the testosterone and sperm-raising benefits without the zuclomiphene burden. Head-to-head research shows enclomiphene produces greater increases in LH, FSH, and total motile sperm count compared to clomiphene, though both raise testosterone.
When you take testosterone, your pituitary stops releasing luteinizing hormone (LH), the signal that tells your Leydig cells to produce testosterone inside the testes and maintain the high local concentration needed for sperm production. hCG binds directly to the LH receptor on Leydig cells, mimicking that missing signal and keeping them active. Studies show that low-dose hCG added to TRT preserves sperm production even when external testosterone fully suppresses the natural hormonal signals. In one case series, hCG combination therapy restored spermatogenesis in 96% of men with testosterone-related infertility.
Before any hormone protocol, get a fasting early-morning total testosterone, LH and FSH (to distinguish whether your problem is in the brain or testes), prolactin, and estradiol. Most importantly, get a semen analysis showing sperm concentration, motility, and morphology. Without a baseline semen analysis, there is no reliable way to know what changed after treatment starts. These results determine which options are actually viable for your situation and give you a reference point to measure improvement.
Take our 2-minute hormone & metabolism quiz to see exactly where you stand — or jump straight to labs or a free screen with our team.